Welcome to LookChem.com Sign In|Join Free

CAS

  • or

115-53-7

Post Buying Request

115-53-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

115-53-7 Usage

Description

Isolated by Ohta from Cocculus diversifolius DC., this alkaloid forms colourless crystals from MeOH. It is stated to possess a powerful reflex action and to be aspasm stimulant, finally causing paralysis and death in toxic doses. It is also said to suppress the hypotensive action of dihydroxyphenylethanolethylamine.

Physical properties

Appearance: acicular crystals (crystallized from benzene). Solubility: soluble in ethanol, acetone, chloroform, and dilute alkali; slightly soluble in water, ether, and benzene. Melting point: 219–221?°C. Specific optical rotation:?– 71° (c?=?2.1, ethanol). Its hydrochloride, crystallization (water or ethanol), decomposed at 278?°C.?Its hydroiodide, needle crystal (crystallized from water), decomposed at 272?°C.?Its picrate, which is yellow needle crystal, decomposed at 176?°C.?Sinomenine is sensitive to light and heat to decompose.

History

The chemical structure of sinomenine is composed of four rings, A, B, C, and D, similar to the structure of morphine. Ring A is a benzene ring, and ring B is a half-chair-shaped, six-member ring. The C ring is a twisted-chair-type, sixmember ring that has an a, β-unsaturated ketone structure attached to the B ring. The D ring is a nitrogen-containing, sixmember ring under the B ring. Its structure is shown below; the current structural modification of sinomenine is mainly focused on the A/C active group. Based on the transformation of the A ring, it was found that the 1-substituted formyl derivative of sinomenine showed the strongest inhibitory effect on the inflammatory response of the mouse ear. The 4-substituted p-chlorobenzoyl-sinomenine has the strongest anti-inflammatory and analgesic activity. The biotransformation and chemical synthesis were also used to prepare the di-sinomenine derivatives linked by carbon and carbon, which was stronger than that of sinomenine and had a strong inhibitory effect on cell inflammatory factors. Sinomenine derivatives of the C ring with a pyrazine ring have a strong inhibitory effect on T, B lymphocyte proliferation reaction, which can be used for the preparation of immunomodulatory drugs. The transformation of C ring carbonyl yielded a series of shift alkali derivatives, with strong anti-inflammatory and analgesic effects. These attempts are important for the development of new drugs.

Uses

weak abortifacient, immunosuppressant, analgesic, antiinflammatory; LD50 (po) 580 mg/kg; (ip) 285 mg/kg(mouse)

Indications

It is mainly used for the treatment of rheumatoid arthritis and other types of rheumatism and arrhythmia in clinical.

Biological Activity

Natural anti-inflammatory morphinan analog. Causes degranulation of mast cells in mammalian tissues to release histamine and suppresses production of proinflammatory cytokines. Also displays antinociceptive activity, possibly through activation of the μ -opioid receptor. Stimulates short-term renewal of human embryonic stem cells (ESCs) in vitro .

Pharmacology

Sinomenine has anti-inflammatory, immunosuppressive, analgesic sedation, antiarrhythmic, detoxification, and other pharmacological effects, while the half-life of sinomenine is short. In addition, sinomenine also causes a strong histamine release, which leads to rash, gastrointestinal reactions, and other side effects, limiting its wide range of clinical applications.1. Effects on central nervous system(a) Analgesic effect: The chemical structure of sinomenine and morphine are similar (Fig.?3). They both act on the central nervous system with a significant analgesic effect, but the mechanisms are different. It has been shown that the analgesic effect of sinomenine has nothing to do with the release of histamine.(b) Sedative effect: Sinomenine has an inhibitory effect on the central nervous system. The sedative effect works by inhibiting the excitement of advanced neurological activity. Sinomenine can also eliminate the “anger” response of mice caused by electrical stimulation, showing a stabilizing effect. In addition, although, like morphine, it had mainly a sedative effect on the central nervous system, sinomenine also has some excitatory effects on some parts of the central nervous system, especially the spinal cord.Other effects on the central nervous system: Sinomenine may, to a slight degree, induce vomiting. Sinomenine also has local anesthetic effects on frog nerve endings and rabbit cornea that could be applied for local infiltration anesthesia.2. Effects on peripheral nervous systemSinomenine can reversibly block the neuromuscular transmission, which showed a concentration-dependent inhibitory effect. Sinomenine had no significant effect on nerve stem excitability and conductivity.3. Impact on cardiovascular systemSinomenine has a significant antihypertensive effect. Sinomenine also has a significant antagonistic effect on ischemic arrhythmia.4. Anti-inflammatory and antiallergic effectsThe anti-inflammatory effect of sinomenine is significant.

Clinical Use

The treatment of rheumatism and rheumatoid arthritis is one of the most important clinical applications of sinomenine. Sinomenine is particularly suitable for the treatment of arrhythmia caused by organic heart disease. Sinomenine is used for the treatment of glomerular disease, which can reduce urinary protein and relieve hematuria symptoms, and the side effects were significantly lower than that of tripterygium glycoside tablets, which are commonly used in clinical practice. In addition, sinomenine can significantly inhibit renal interstitial fibrosis and the production of tissue growth and growth factor TGF-β1. Sinomenine can significantly delay the development of chronic renal failure and effectively treat ankylosing spondylitis.

Purification Methods

Crystallise the salt from water (1g/1.5mL) or EtOH. The free base [115-53-7] M 329.4, has m 161o (from EtOH) (and again at 182o) after crystallisation from *C6H6, and [] D -78.9o (c 1, EtOH). The picrate has m 159-162o(dec) (from H2O). [Beilstein 21 II 470, 21 III/IV 6670.]

References

Ohta., Ber. ges. Physiol., 33, 352 (1925) Ohta, Kitasato., Arch. expo Med., 6, 259, 283 (1925) Raymond-Hamet., Compt. rend. Soc. Biol., 125, 509 (1937)

Check Digit Verification of cas no

The CAS Registry Mumber 115-53-7 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,1 and 5 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 115-53:
(5*1)+(4*1)+(3*5)+(2*5)+(1*3)=37
37 % 10 = 7
So 115-53-7 is a valid CAS Registry Number.
InChI:InChI=1/C19H23NO4/c1-20-7-6-19-10-14(21)16(24-3)9-12(19)13(20)8-11-4-5-15(23-2)18(22)17(11)19/h4-5,9,12-13,22H,6-8,10H2,1-3H3/t12-,13+,19-/m1/s1

115-53-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name Sinomenine

1.2 Other means of identification

Product number -
Other names Morphinan-6-one, 7,8-didehydro-4-hydroxy-3,7-dimethoxy-17-methyl-, (9α,13α,14α)-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:115-53-7 SDS

115-53-7Synthetic route

C22H27NO5
1246560-79-1

C22H27NO5

sinomenine
115-53-7

sinomenine

Conditions
ConditionsYield
With Aliquat 336; potassium hydroxide In water at 60℃; for 2h;99%
4-acetyl-sinomenine
22610-64-6

4-acetyl-sinomenine

sinomenine
115-53-7

sinomenine

Conditions
ConditionsYield
With Aliquat 336; potassium hydroxide In water at 60℃; for 1h;99%
Sinomenine Hydrochloride
6080-33-7, 61487-22-7, 70617-35-5

Sinomenine Hydrochloride

sinomenine
115-53-7

sinomenine

Conditions
ConditionsYield
With ammonium hydroxide94%
With ammonium hydroxide94%
sinomenine N-oxide
1000026-77-6

sinomenine N-oxide

sinomenine
115-53-7

sinomenine

Conditions
ConditionsYield
With FAD; NADH In aq. phosphate buffer at 37℃; for 2h; Reagent/catalyst;
sinomenine
115-53-7

sinomenine

(Z,E)-sinomenine oxime
6106-71-4

(Z,E)-sinomenine oxime

Conditions
ConditionsYield
With hydroxylamine hydrochloride; Aliquat 336 In water at 60℃; for 1h;99%
With hydroxylamine hydrochloride; sodium acetate In methanol at 80℃; for 15h;99%
With hydroxylamine hydrochloride; sodium acetate In ethanol for 8h; Reflux;95%
ethanol
64-17-5

ethanol

sinomenine
115-53-7

sinomenine

4-O-ethylsinomenine
1246560-80-4

4-O-ethylsinomenine

Conditions
ConditionsYield
With di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran at 20℃; for 12.5h; Mitsunobu reaction;99%
1-bromo-octane
111-83-1

1-bromo-octane

sinomenine
115-53-7

sinomenine

4-O-(n-octyl)sinomenine
1372785-17-5

4-O-(n-octyl)sinomenine

Conditions
ConditionsYield
With potassium carbonate In acetone at 60℃;99%
sinomenine
115-53-7

sinomenine

sinomenine N-oxide
1000026-77-6

sinomenine N-oxide

Conditions
ConditionsYield
With dihydrogen peroxide at 20℃; for 24h;98.7%
With 3-chloro-benzenecarboperoxoic acid In dichloromethane at 0℃; for 0.5h;76%
With dihydrogen peroxide for 72h; Inert atmosphere;60%
With dihydrogen peroxide for 48h;
With dihydrogen peroxide at 20℃; for 60h;
1-Bromononane
693-58-3

1-Bromononane

sinomenine
115-53-7

sinomenine

4-O-(n-nonyl)sinomenine
1351932-96-1

4-O-(n-nonyl)sinomenine

Conditions
ConditionsYield
With potassium carbonate In acetone at 60℃;98%
propyl bromide
106-94-5

propyl bromide

sinomenine
115-53-7

sinomenine

4-O-(n-propyl)sinomenine
1372785-14-2

4-O-(n-propyl)sinomenine

Conditions
ConditionsYield
With potassium carbonate In acetone at 60℃;98%
sinomenine
115-53-7

sinomenine

(R)-disinomenine

(R)-disinomenine

(S)-disinomenine

(S)-disinomenine

Conditions
ConditionsYield
With potassium hydroxide; potassium permanganate at 20℃; aq. phosphate buffer; stereoselective reaction;A 97.7%
B 2.3%
With manganese(IV) oxide In methanol at 20℃;A 45%
B 53%
1-bromo-hexane
111-25-1

1-bromo-hexane

sinomenine
115-53-7

sinomenine

4-O-(n-hexyl)sinomenine
1351932-95-0

4-O-(n-hexyl)sinomenine

Conditions
ConditionsYield
With potassium carbonate In acetone at 60℃;97%
phenylhydrazine hydrochloride
59-88-1

phenylhydrazine hydrochloride

sinomenine
115-53-7

sinomenine

C25H29N3O3

C25H29N3O3

Conditions
ConditionsYield
With Aliquat 336 In water at 60℃; for 3h;96%
1-bromo-butane
109-65-9

1-bromo-butane

sinomenine
115-53-7

sinomenine

4-O-(n-butyl)sinomenine
1351932-94-9

4-O-(n-butyl)sinomenine

Conditions
ConditionsYield
With potassium carbonate In acetone at 60℃;96%
1-Bromoheptane
629-04-9

1-Bromoheptane

sinomenine
115-53-7

sinomenine

4-O-(n-heptyl)sinomenine
1372785-16-4

4-O-(n-heptyl)sinomenine

Conditions
ConditionsYield
With potassium carbonate In acetone at 60℃;96%
1-Bromopentane
110-53-2

1-Bromopentane

sinomenine
115-53-7

sinomenine

4-O-amylsinomenine
1372785-15-3

4-O-amylsinomenine

Conditions
ConditionsYield
With potassium carbonate In acetone at 60℃;96%
1-bromo dodecane
112-29-8

1-bromo dodecane

sinomenine
115-53-7

sinomenine

4-O-(n-decyl)sinomenine
1372785-18-6

4-O-(n-decyl)sinomenine

Conditions
ConditionsYield
With potassium carbonate In acetone at 60℃;96%
2-propynyl chloride
624-65-7

2-propynyl chloride

sinomenine
115-53-7

sinomenine

7,8-didehydro-4-propargylhydroxy-3,7-dimethoxy-17-methylmorphinan-6-one
1354636-54-6

7,8-didehydro-4-propargylhydroxy-3,7-dimethoxy-17-methylmorphinan-6-one

Conditions
ConditionsYield
With potassium hydroxide In N,N-dimethyl-formamide at 20℃; for 6h;96%
With potassium hydroxide In N,N-dimethyl-formamide at 70℃;96%
sinomenine
115-53-7

sinomenine

1-iodosinomenine
945761-25-1

1-iodosinomenine

Conditions
ConditionsYield
With N-iodo-succinimide In dichloromethane at 20℃; for 0.166667h;92%
With N-iodo-succinimide In dichloromethane at 20℃; for 4h;84.6%
With N-iodo-succinimide In chloroform at 20℃;55%
Octanoic acid
124-07-2

Octanoic acid

sinomenine
115-53-7

sinomenine

4-O-capryloylsinomenine
1351933-02-2

4-O-capryloylsinomenine

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane Reflux;91%
sinomenine
115-53-7

sinomenine

methyl iodide
74-88-4

methyl iodide

(R)-5-hydroxy-2.6-dimethoxy-3-oxo-4a-(2-dimethylamino-ethyl)-3.4.4a.9-tetrahydro-phenanthrene

(R)-5-hydroxy-2.6-dimethoxy-3-oxo-4a-(2-dimethylamino-ethyl)-3.4.4a.9-tetrahydro-phenanthrene

Conditions
ConditionsYield
In acetonitrile for 20h; Inert atmosphere;90%
sinomenine
115-53-7

sinomenine

C19H24N2O4

C19H24N2O4

Conditions
ConditionsYield
With chloro(meso-tetrakis(2,6-dichlorophenyl)porphyrinato)manganese(III); O-(2,4-dinitrophenyl)hydroxylamine In dichloromethane for 2h;90%
benzyl alcohol
100-51-6

benzyl alcohol

sinomenine
115-53-7

sinomenine

O-Benzylsinomenine
160693-95-8

O-Benzylsinomenine

Conditions
ConditionsYield
With triphenylphosphine; diethylazodicarboxylate In tetrahydrofuran for 10h; Ambient temperature;89%
With triphenylphosphine; diethylazodicarboxylate In tetrahydrofuran for 10h; Ambient temperature;89%
oenanthic acid
111-14-8

oenanthic acid

sinomenine
115-53-7

sinomenine

4-O-(n-heptanoyl)sinomenine
1372785-04-0

4-O-(n-heptanoyl)sinomenine

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane Reflux;89%
sinomenine
115-53-7

sinomenine

ent-4-hydroxy-3-methoxy-17-methyl-morphinane-6,7-dione
510-43-0

ent-4-hydroxy-3-methoxy-17-methyl-morphinane-6,7-dione

Conditions
ConditionsYield
With hydrogenchloride In water at 80℃;86%
With hydrogenchloride; water for 10h; Inert atmosphere; Reflux;81%
With hydrogenchloride
With hydrogen bromide; acetic anhydride; acetic acid
sinomenine
115-53-7

sinomenine

valeric acid
109-52-4

valeric acid

4-O-valeroylsinomenine
1372785-01-7

4-O-valeroylsinomenine

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane Reflux;86%
1-azido-3,6,9,12,15,18-hexaoxahenicosan-21-oic acid
361189-66-4

1-azido-3,6,9,12,15,18-hexaoxahenicosan-21-oic acid

sinomenine
115-53-7

sinomenine

C34H50N4O11

C34H50N4O11

Conditions
ConditionsYield
With dmap; 3-{[(ethylimino)methylene]-amino}-N,N,N-trimethyl-1-propanaminium iodide In dichloromethane at 20℃;86%
hexanoic acid
142-62-1

hexanoic acid

sinomenine
115-53-7

sinomenine

4-O-caproylsinomenine
1351933-01-1

4-O-caproylsinomenine

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane Reflux;84%
nonanoic acid
112-05-0

nonanoic acid

sinomenine
115-53-7

sinomenine

4-O-(n-nonanoyl)sinomenine
1372785-07-3

4-O-(n-nonanoyl)sinomenine

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane Reflux;82%
stearic acid
57-11-4

stearic acid

sinomenine
115-53-7

sinomenine

4-stearylsinomenine

4-stearylsinomenine

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 48h; Inert atmosphere;80.5%
sinomenine
115-53-7

sinomenine

4-hydroxy-3,7β-dimethoxy-17-methylmorphinan-6-one
65120-75-4

4-hydroxy-3,7β-dimethoxy-17-methylmorphinan-6-one

Conditions
ConditionsYield
With palladium 10% on activated carbon; hydrogen In water79%
With pyridine; platinum Hydrogenation;
With sodium dithionite; water

115-53-7Related news

Sinomenine (cas 115-53-7) enhances microglia M2 polarization and attenuates inflammatory injury in intracerebral hemorrhage08/30/2019

Microglia polarization plays a vital role in brain inflammatory injury following intracerebral hemorrhage (ICH). Previous studies have shown that sinomenine possesses potential immunoregulatory capabilities. However, microglia polarization's exact mechanisms in ICH remain uncertain. Therefo...detailed

Sinomenine (cas 115-53-7) contributes to the inhibition of the inflammatory response and the improvement of osteoarthritis in mouse-cartilage cells by acting on the Nrf2/HO-1 and NF-κB signaling pathways08/29/2019

Pathological changes, such as articular cartilage degeneration, destruction, and hyperosteogeny, are regarded as the main features of osteoarthritis (OA). Sinomenine (SIN) is a monomeric component purified from the plant Sinomenium acutum which has been found to have anti-inflammatory effects, h...detailed

In situ hexagonal liquid crystal for intra-articular delivery of Sinomenine (cas 115-53-7) hydrochloride08/28/2019

The aim of this study was to investigate the release behaviors of sinomenine hydrochloride loaded via in situ hexagonal liquid crystal (ISH), and its potential to improve the local bioavailability in knee joints of sinomenine hydrochloride (SMH) after intra-articular administration. The ISH was ...detailed

Protective effects of Sinomenine (cas 115-53-7) against LPS-induced inflammation in piglets08/27/2019

The aim of this study was to investigate in piglets, the anti-endotoxin and anti-inflammatory effects of sinomenine, an agent commonly found in Chinese herbal medicines. In high-, middle- and low-dose sinomenine groups, piglets were initially challenged with endotoxin (i.e., 1 mg lipopolysacchar...detailed

Co-administration with simvastatin or lovastatin alters the pharmacokinetic profile of Sinomenine (cas 115-53-7) in rats through cytochrome P450-mediated pathways08/26/2019

AimsSinomenine, an anti-rheumatoid arthritis drug used in China for decades, is usually co-administered with cardiovascular (CV) drugs to reduce arthritis-related risk of cardiovascular diseases. This study was to investigate whether and how CV drugs affect the pharmacokinetic profile of sinomenine.detailed

Simultaneous determination of alkaloids dicentrine and Sinomenine (cas 115-53-7) in Stephania epigeae by 1H NMR spectroscopy08/25/2019

Stephania epigaea Lo is an important herbal medicine used as antiphlogistic and analgesic drugs. Its major components are dicentrine (1) and sinomenine (2). In the present study, a rapid, accurate, and precise method for simultaneous quantitation of dicentrine (1) and sinomenine (2) in S. epigea...detailed

Pharmacokinetics of Sinomenine (cas 115-53-7) hydrochloride cubic liquid crystal injection based on microdialysis technology08/24/2019

ObjectiveThe purpose of this study was to develop an injectable in situ liquid crystal formulation for intra-articular administration and evaluate its pharmacokinetics characteristics on Microdialysis Technology.detailed

Sinomenine (cas 115-53-7) inhibits proliferation, migration, invasion and promotes apoptosis of prostate cancer cells by regulation of miR-23a08/23/2019

Background Prostate cancer is an extremely common disease in males, and the mortality of prostate cancer has been rising year by year. Sinomenine has been reported to exhibit anti-tumor effect on various cancers, but the function of Sinomenine in prostate cancer remains unclear. The study aimed ...detailed

Research articlePossible involvement of the μ opioid receptor in the antinociception induced by Sinomenine (cas 115-53-7) on formalin-induced nociceptive behavior in mice08/22/2019

Sinomenine, an alkaloid originally isolated from the roots and the rhizome of Sinomenium acutum is used as a traditional Chinese herbal medicines for rheumatoid arthritis and neuralgia. The aims of this study were to investigate the effects of oral administration of shinomenine on formalin-induc...detailed

115-53-7Relevant articles and documents

Metabolic mechanism and anti-inflammation effects of sinomenine and its major metabolites N-demethylsinomenine and sinomenine-N-oxide

Kou, Fang,Li, Qiang,Lyu, Chunming,Wang, Yuyan,Wei, Hai,Zhou, Wenbin

, (2020)

Aims: Sinomenine (SIN) is clinically used as an anti-rheumatic drug. However, the metabolic and pharmacological mechanisms of SIN combined with its metabolites are unclear. This study aims to explore the cyclic metabolic mechanism of SIN, the anti-inflammation effects of SIN and its major metabolites (N-demethylsinomenine (DS) and sinomenine-N-oxide (SNO)), and the oxidation property of SNO. Materials and methods: SIN was administrated to rats via gavage. Qishe pills (a SIN-containing drug) were orally administrated to humans. The bio-samples were collected to identify SIN's metabolites. Enzymatic and non-enzymatic incubations were used to reveal SIN's metabolic mechanism. Impacts of SIN, SNO and DS on the inflammation-related cytokine's levels and nuclear translocation of NF-κB were evaluated in LPS-induced Raw264.7 cells. ROS induced by SNO (10 μM) was also assessed. Key findings: CYP3A4 and ROS predominantly mediated the formation of SNO, and CYP3A4 and CYP2C19 primarily mediated the formation of DS. Noteworthily, SNO underwent N-oxide reduction both enzymatically, by xanthine oxidase (XOD), and non-enzymatically, by ferrous ion and heme moiety. The levels of IL-6 and TNF-α and nuclear translocation of NF-κB were ameliorated after pretreatment of SIN in LPS-induced Raw264.7 cells, while limited attenuations were observed after pretreatment of DS (SNO) even at 200 μM. In contrast, SNO induced ROS production. Significance: This study elucidated that SIN underwent both enzymatic and non-enzymatic cyclic metabolism and worked as the predominant anti-inflammation compound, while SNO induced ROS production, suggesting more studies of SIN combined with SNO and DS are necessary in case of DDI and potential toxicities.

Design and synthesis of C-ring quinoxaline-substituted sinomenine 1,2,3-triazole derivatives via click reactions

Chen, Xia,Dong, Ling,Gu, Chengwen,Jin, Jie,Lu, Tong,Pan, Hongmei,Tao, Naili,Wang, Ao,Wu, Xuedan,Zhang, Kehua

, p. 699 - 704 (2020/06/03)

The synthesis of C-ring quinoxaline-substituted sinomenine 1,2,3-triazole derivatives at the 4-OH via click reactions is accomplished, and a total of 16 novel sinomenine double N-heterocyclic derivatives are obtained in 74%–95% yields. The C-ring is first transformed into a 1,2-diketone structure under the action of hydrochloric acid, and then reacted with o-phenylenediamine to obtain a C-ring quinoxaline-substituted structure. The 4-OH of sinomenine reacts with chloropropyne to give an alkynyl sinomenine, and then reacts with sodium azide and various benzyl chlorides to give the target compounds. All the synthesized derivatives are characterized by Fourier-transform infrared spectrometry, high resolution mass spectrometry, 1H NMR, and 13C NMR spectroscopy.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 115-53-7